A monthly list of the strong stocks big funds are buying,
plus the Meigu Barometer after every US close: what to buy, and when to add or take cover.
Free to join · no credit card
Proprietary fund buying and selling data, turned into a list of strong stocks each month.
Four pillars give the market a weather score after every close: add, or take cover.
Which US industries money is flowing into and out of, every day.
Any US ticker, turned into a sourced research report.
Large institutions and hedge funds run internal macro market regime models to decide whether to buy in, add leverage or risk off. The Meigu Barometer opens up the results of this framework: five weather levels, updated after every US close, so retail investors can adjust their positions too.
Updated after the Nov 18 close
Each pillar is scored, the four are averaged, and the result becomes one of five levels of weather, from Storm to Bright Sun. The sunnier, the friendlier for US stocks.
Updated every US trading day at about 5:30pm ET, early next morning in Asia.
Bold switches between cash, QQQ (1x) and QLD (the 2x Nasdaq-100 ETF); Steady switches between cash and QQQ only.
Adjust at the next US open. That's about 31 times a year for Bold and 10 for Steady.
Hypothetical backtest, not a record of real trades; no trading costs or taxes. QLD is a daily-reset 2x leveraged ETF and swings about twice as much as QQQ. Past performance does not guarantee future results. For information and education only; not investment advice.
Public: last week's weather · Free members: the previous trading day · Pro: the same day after the close, with positions
Bold backtest: following one week late, the same $10,000 ended up about $327k smaller.
Free · No credit card · Updated after every US close
Want the same-day reading and position? Go Pro for under US$0.27 a day →The list comes from our proprietary data on fund buying and selling: each month's strong stocks, each with a buy / hold / sell signal, a rank, 1/3/6-month performance and its industry. Here are the top 3.
Latest list: November 2026
Pro members see this month's full list, rankings and the report archive; free members see reports 2 months later.
The 20 buy signals in the November list with the biggest gains this year, as an equal-weight basket with $10,000 from 2026-01-02, against SPY over the same period.
Data through the Nov 18 close
The 20 were picked for their gains this year as of the 2026-10-30 close, so this chart mostly looks back at them. It is not what following the list would have earned. Closing prices, without dividends or trading costs.
Tracks US industry ETF inflows, outflows, and short-term momentum shifts.
Enter any US ticker and get a research report: price zones, catalysts, risks and an evidence score, with a source for every point.
Full use with Pro; free members can try it a limited number of times.
Use it to dig into stocks you find in the monthly report.
Start free with delayed reports. Upgrade for this month's report and the same-day barometer.
Delayed reports (2 months), this month's top 3 stocks and the previous day's Meigu Barometer.
Get Free AccessOne full list a month (100 buy signals with rankings this month), the report archive, the barometer and position after every US close, and unlimited AI Stock Analyst.
Upgrade to Pro| Compare plans | Free Member | Pro Member |
|---|---|---|
| Monthly strong-stock report | 2 months late | Current month |
| Tickers and rankings | Top 3 this month | Full list |
| Report archive | ||
| Meigu Barometer | Previous trading day | Same day + daily position |
| AI Stock Analyst | Limited |
11月強勢股聚焦GKOS、MRNA與REGN,涵蓋眼科新品商業化、mRNA癌症疫苗與生物製藥。本文比較股價、財報、現金流及估值,辨識基本面支撐與預期風險。下月應追蹤GKOS新品銷售與保險給付、MRNA臨床申報與現金消耗、REGN藥品銷售及獲利;若財測下修、臨床延後或估值過熱,應檢視持有與追價風險。
2026 年 11 月美股強勢股排名顯示,醫療保健成為本期最具代表性的強勢族群。GKOS 受惠眼科創新產品商業化與財報成長,MRNA 憑藉疫苗核准及癌症療法臨床進展推動價值重估,REGN 則以多元藥品銷售與獲利成長展現基本面韌性。本期研究透過價格強度、趨勢品質、產業催化與基本面四大構面,篩選出前 10 名代表性強勢股,並分析其成長延續性、估值風險與下月關鍵追蹤指標。
2026年10月市場在能源價格急升、通膨壓力回溫與AI資本支出疑慮下轉趨震盪。原油走強推升通膨與利率預期,科技股與高Beta資產則承受估值壓力。整體訊號偏弱且分化加劇,投資策略宜轉向中性偏防禦,保留部分現金、降低高波動部位,並提高高品質股票、黃金與防禦型資產配置。展望11月,Fed政策、油價、通膨與企業財測將是市場方向的重要驗證指標。
No credit card. Free members get reports 2 months later, this month's top 3 and the previous day's barometer.
No credit card · cancel Pro anytime